Implementation of Global License of Aureus Pharma's Knowledge Databases by GlaxoSmithKline
Advertisement
Aureus Pharma announced that GlaxoSmithKline (GSK) has signed a multi-year license for Aureus Pharma's AurSCOPE Knowledge databases. Researchers at GSK's global research and development centers will gain access to Aureus' Knowledge databases including AurSCOPE GPCR, Ion Channel, hERG, and ADME/Drug-Drug Interactions. In addition, GSK has licensed the recently released AurSCOPE Kinase product making it the first customer of this knowledge base. Financial details were not disclosed.
Most read news
Other news from the department research and development

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Heat storage: Scientists develop material that is stable, efficient and eco-friendly
Toward a test strip for detecting TNT and other explosives in water

Atomic structure of ultrasound material not what anyone expected
The inclusion of small molecules changes the distance between layers in lamellar material
U of A-led experiment at CERN could rewrite laws of physics

Tetravinylallene, a small but powerful molecule, has been synthesized for the first time - Strained, Symmetric, and New
